Lymphoma & Plasma Cell Disorders
Conference Coverage
Most community-based oncologists skip biomarker testing
Survey shows that 48% of community clinicians use biomarker testing to guide treatment decisions, compared with 73% of academic clinicians.
Article
Evans’ Syndrome in Undiagnosed Small Lymphocytic Lymphoma: Case Report and Literature Review
News
FDA warns of higher death risk with Pepaxto in multiple myeloma
The FDA also hinted at “a future public meeting to discuss the safety findings and explore the continued marketing of Pepaxto,” which has a price...
Conference Coverage
Experimental antibody-drug conjugate shown active against r/r DLBCL
News
Choosing the right R-CHOP dosage for elderly patients with DLBCL
Article
The power and promise of social media in oncology
Dr. Alan Lyss describes a recent presentation on the role of social media in oncology.
Clinical Topics & News
Atrial Fibrillation and Bleeding in Patients With Chronic Lymphocytic Leukemia Treated with Ibrutinib in the Veterans Health Administration
Although ibrutinib is associated with increased bleeding-related adverse events, the risk for patients with chronic lymphocytic leukemia is...
Conference Coverage
Personalized cancer vaccine shows early promise across tumor types
The vaccine consists of patient-specific synthetic neoantigen peptides and is given to patients in the adjuvant setting.
Article
Cancer screening stopped by pandemic: Repercussions to come?
News
Steroids can be stopped in some older multiple myeloma patients
